PROCEPT BioRobotics (PRCT) Current Leases (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Current Leases data on file, last reported at $2.4 million in Q1 2026.

• Quarterly Current Leases rose 18.91% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 18.91% YoY) and the FY2025 annual result came in at $2.2 million, up 15.92% from the prior year.
• Current Leases advanced to $2.4 million in Q1 2026 per PRCT's latest filing, from $2.2 million in the prior quarter.
• Across five years, Current Leases topped out at $3.0 million in Q1 2023 and bottomed at $1.7 million in Q4 2023.
• The 5-year median for Current Leases is $2.1 million (2022), against an average of $2.1 million.
• The widest annual swing landed in 2023, when Current Leases surged 37.46%; it then sank 43.26% in 2024.
• Tracing PRCT's Current Leases over 5 years: stood at $2.1 million in 2022, then retreated by 20.95% to $1.7 million in 2023, then grew by 13.49% to $1.9 million in 2024, then rose by 15.92% to $2.2 million in 2025, then grew by 6.5% to $2.4 million in 2026.
• Per Business Quant, the three latest PRCT Current Leases figures stand at $2.4 million (Q1 2026), $2.2 million (Q4 2025), and $2.1 million (Q3 2025).

Peer Comparison